Results 1 to 10 of about 6,072 (179)

Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders [PDF]

The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2023
Owing to their superior pharmacokinetic and pharmacodynamic profiles, potassium-competitive acid blockers (P-CABs) score over proton pump inhibitors (PPIs) in the treatment of gastric acid-related disorders and may provide clinical benefit in the ...
Mun Young Cho, Yu Kyung Cho
doaj   +1 more source

Gastroprotective effects of methanolic extract of kratom leaves on gastric ulcer and reflux esophagitis in rats [PDF]

Songklanakarin Journal of Science and Technology (SJST), 2018
Kratom (Mitragyna speciosa (Korth.) Havil.) is a tropical tree indigenous to Thailand. In traditional medicine, it has been used to treat diarrhea, peptic ulcer, stomach ache or gastric upsets.
Somsmorn Chittrakarn, Nisaudah Radenahmad, Sujitra Kaewsara, Wandee Udomuksorn, Niwat Keawpradub, Pimpimol Phukpattaranont   +5 more
doaj   +1 more source

Esophagitis in a high H. pylori prevalence area: severe disease is rare but concomitant peptic ulcer is frequent. [PDF]

PLoS ONE, 2011
BACKGROUND: Few data are available on the prevalence of erosive and severe esophagitis in Western countries. OBJECTIVE: To retrospectively determine the prevalence and the factors predicting erosive esophagitis and severe esophagitis in a large series of
Julio Ponce, Xavier Calvet, Xavier Calvet, Marta Gallach, Marta Ponce, Esophagitis Study Group of the Asociación Española de Gastroenterología (AEG)   +5 more
doaj   +1 more source

Acid Suppressive Drugs [PDF]

The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2022
Histamine H2 receptor antagonists (H2RAs) suppress gastric acid production by blocking H2 receptors in parietal cells. Studies have shown that proton pump inhibitors (PPIs) are superior to H2RAs as a treatment for acid-related disorders, such as peptic ...
Cheol Min Shin
doaj   +1 more source

A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children

Frontiers in Pharmacology, 2022
Proton pump inhibitors (PPIs) are among the most prescribed drugs worldwide and include omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole.
Valeria Dipasquale, Giuseppe Cicala, Edoardo Spina, Claudio Romano   +3 more
doaj   +1 more source

Endoscopic evaluation of patients with dyspepsia in a secondary referral hospital in Egypt

Alexandria Journal of Medicine, 2015
Background: Dyspepsia is a common clinical problem. More than half of patients presenting with dyspepsia have no detectable lesion for their symptoms. The common organic causes of dyspepsia include peptic ulcer, esophagitis and cancer.
Ahmed Gado, Basel Ebeid, Aida Abdelmohsen, Anthony Axon   +3 more
doaj   +1 more source

Neither genotype nor the gastric colonization site of Helicobacter pylori are predictive factors for the development of erosive esophagitis in patients with peptic ulcer disease, 1 year after eradication O genótipo e o local no estômago de isolamento do Helicobacter pylori em pacientes com úlcera péptica não são fatores preditivos para o desenvolvimento de esofagite erosiva 1 ano após a erradicação da bactéria

Arquivos de Gastroenterologia, 2009
CONTEXT: Whether Helicobacter pylori infection is a protective or predisposing factor for the development of gastroesophageal reflux disease remains controversial. The most virulent strains, such as those expressing the cytotoxin-associated gene A (CagA),
Carlos Alexandre Gonçalves Batista, Fernando Marcuz Silva, Ricardo Correa Barbuti, Jaime Natan Eisig, Rejane Mattar, Tomás Navarro-Rodriguez   +5 more
doaj   +1 more source

Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan

JGH Open, 2021
Background and Aim The aim of the present study was to examine the lifestyle‐ and comorbidity‐related determinant factors of the prescription of proton pump inhibitors (PPIs) for patients in whom Helicobacter pylori has been eradicated, and to evaluate ...
Furitsu Shimada, Hiroyoshi Endo, Ayako Takamori, Takuya Matsunaga, Shun Fujimoto, Shimpei Shirai, Toshihiko Kakiuchi, Takashi Akutagawa, Yasuhisa Sakata, Koichi Node, Kohei Yamanouchi, Shotaro Nakamura, Kazuma Fujimoto, Motohiro Esaki   +13 more
doaj   +1 more source

Risks of substance uses, alcohol flush response, Helicobacter pylori infection and upper digestive tract diseases—An endoscopy cross‐sectional study

Kaohsiung Journal of Medical Sciences, 2019
This study examines the effects of environmental hazards, including tobacco, alcohol/alcohol flush response, areca nut, and Helicobacter pylori (H pylori) infection on upper digestive diseases.
Yun‐Shiuan Chuang, Meng‐Chieh Wu, Yao‐Kuang Wang, Yi‐Hsun Chen, Chao‐Hung Kuo, Deng‐Chyang Wu, Ming‐Tsang Wu, I‐Chen Wu   +7 more
doaj   +1 more source

Review – Helicobacter pylori & non-malignant upper GI diseases [PDF]

Microbiota in Health and Disease, 2021
Helicobacter pylori remains a crucial factor in the development of gastrointestinal (GI) diseases including chronic gastritis, peptic ulcer disease (PUD) and gastric cancer, even decades after its discovery.
V. Ivanova, R. Jaensch, A. Link, D. Bordin   +3 more
doaj   +1 more source